[Expression and clinical significance of circadian gene Per2 in non-small cell lung cancer].

Chuang Chi; Zhi feng He; Y. Liu; Xiao ming Lin; Cheng chao Sun

[Expression and clinical significance of circadian gene Per2 in non-small cell lung cancer].

Chuang Chi, Zhi feng He, Y. Liu, Xiao ming Lin, Cheng chao Sun

Research output: Contribution to journal › Article › peer-review

Abstract

To detect the expression of Per2 in non-small cell lung cancer (NSCLC), and analyze its clinical significance. The expression of Per2 was determined in 60 NSCLC and 20 normal lung tissues by immunohistochemical assay, and the relationship between Per2 expression and clinicopathological features was analyzed. The positive expression rates of Per2 in NSCLC and normal lung tissues were 71.7% and 95.0%, respectively (P < 0.05). The expression of Per2 in NSCLC was correlated with pathological differentiation and TNM stage (P < 0.05). The expression of Per2 in NSCLC is decreased. The negative expression of Per2 may contribute to the development and invasion in NSCLC.

Original language	English
Pages (from-to)	129-131
Number of pages	3
Journal	Chinese Journal of Oncology
Volume	35
Issue number	2
Publication status	Published - Jan 1 2013
Externally published	Yes

ASJC Scopus subject areas

General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{2d0848134d6e4c05aed724d49af95f17,

title = "[Expression and clinical significance of circadian gene Per2 in non-small cell lung cancer].",

abstract = "To detect the expression of Per2 in non-small cell lung cancer (NSCLC), and analyze its clinical significance. The expression of Per2 was determined in 60 NSCLC and 20 normal lung tissues by immunohistochemical assay, and the relationship between Per2 expression and clinicopathological features was analyzed. The positive expression rates of Per2 in NSCLC and normal lung tissues were 71.7% and 95.0%, respectively (P < 0.05). The expression of Per2 in NSCLC was correlated with pathological differentiation and TNM stage (P < 0.05). The expression of Per2 in NSCLC is decreased. The negative expression of Per2 may contribute to the development and invasion in NSCLC.",

author = "Chuang Chi and He, {Zhi feng} and Y. Liu and Lin, {Xiao ming} and Sun, {Cheng chao}",

year = "2013",

month = jan,

day = "1",

language = "English",

volume = "35",

pages = "129--131",

journal = "Chinese Journal of Oncology",

issn = "0253-3766",

publisher = "Chinese Academy of Medical Sciences",

number = "2",

}

TY - JOUR

T1 - [Expression and clinical significance of circadian gene Per2 in non-small cell lung cancer].

AU - Chi, Chuang

AU - He, Zhi feng

AU - Liu, Y.

AU - Lin, Xiao ming

AU - Sun, Cheng chao

PY - 2013/1/1

Y1 - 2013/1/1

N2 - To detect the expression of Per2 in non-small cell lung cancer (NSCLC), and analyze its clinical significance. The expression of Per2 was determined in 60 NSCLC and 20 normal lung tissues by immunohistochemical assay, and the relationship between Per2 expression and clinicopathological features was analyzed. The positive expression rates of Per2 in NSCLC and normal lung tissues were 71.7% and 95.0%, respectively (P < 0.05). The expression of Per2 in NSCLC was correlated with pathological differentiation and TNM stage (P < 0.05). The expression of Per2 in NSCLC is decreased. The negative expression of Per2 may contribute to the development and invasion in NSCLC.

AB - To detect the expression of Per2 in non-small cell lung cancer (NSCLC), and analyze its clinical significance. The expression of Per2 was determined in 60 NSCLC and 20 normal lung tissues by immunohistochemical assay, and the relationship between Per2 expression and clinicopathological features was analyzed. The positive expression rates of Per2 in NSCLC and normal lung tissues were 71.7% and 95.0%, respectively (P < 0.05). The expression of Per2 in NSCLC was correlated with pathological differentiation and TNM stage (P < 0.05). The expression of Per2 in NSCLC is decreased. The negative expression of Per2 may contribute to the development and invasion in NSCLC.

UR - http://www.scopus.com/inward/record.url?scp=84886673620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886673620&partnerID=8YFLogxK

M3 - Article

C2 - 23714668

AN - SCOPUS:84886673620

SN - 0253-3766

VL - 35

SP - 129

EP - 131

JO - Chinese Journal of Oncology

JF - Chinese Journal of Oncology

IS - 2

ER -

[Expression and clinical significance of circadian gene Per2 in non-small cell lung cancer].

Abstract

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this